Why this is a Big Deal? As we know, private insurers follow suit once Medicare makes a decision such as this. This portends well for genetic testing to become routine standard of care for patients with advanced cancers. “Insurance coverage should precede rather...
Eric Lefkofsky (CEO of Tempus and co-founder of Groupon): “Treating a cancer patient without the benefit of modern software is the same as driving at night without headlights. If you don’t introduce some amount of data, you will end up going down the wrong path.” AI...
We are excited to launch the first Precision Medicine World Conference (PMWC) at the University of Michigan June 6-7, 2018. The University of Michigan’s Michigan is among the leaders in precision medicine and one of the top NIH grant recipients. Its current areas of...
“Every individual holds a valuable piece of the puzzle to understand disease and health, and researchers are all in need of more data. Discovery is hindered by putting the majority of data into small silos. Breaking down data silos and bringing individuals together...
It’s been an announcement-packed JPMorgan Healthcare Conference in San Francisco this week! A number of testing companies had exciting business announcements including Genomic Health (which reached the expected profitability in 2017), Foundation Medicine(which may...
The cost of health care has been rising year over year – affecting everyone — via company-sponsored health insurance public insurance such as Medicare and Medicaid or private insurance. Chronic illness is responsible for 85 percent of health care costs, but the...
PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.
View the top 3 talks from PMWC here (password: top-videos).
